37 related articles for article (PubMed ID: 11344244)
1. Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues.
Busuttil BE; Frauman AG
J Clin Endocrinol Metab; 2001 May; 86(5):2315-9. PubMed ID: 11344244
[TBL] [Abstract][Full Text] [Related]
2. Extrathyroidal manifestations of Graves' disease: a 2014 update.
Bartalena L; Fatourechi V
J Endocrinol Invest; 2014 Aug; 37(8):691-700. PubMed ID: 24913238
[TBL] [Abstract][Full Text] [Related]
3. Acute autoimmune myocarditis as a manifestation of Graves' disease: A case report and review of the literature.
Lancaster ST; Koons KL; Lee YJ; Mazimba S; Kwon Y
Clin Case Rep; 2019 Aug; 7(8):1489-1493. PubMed ID: 31428374
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Hypothyroidism - What is Responsible for its Association with Cardiovascular Disease?
Sorisky A
Eur Endocrinol; 2016 Aug; 12(2):96-98. PubMed ID: 29632595
[TBL] [Abstract][Full Text] [Related]
5. Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells.
Dotan I; Roche PJ; Paliouras M; Mitmaker EJ; Trifiro MA
PLoS One; 2016; 11(2):e0149723. PubMed ID: 26901566
[TBL] [Abstract][Full Text] [Related]
6. Exogenous thyrotropin improves renal function in euthyroid patients, while serum creatinine levels are increased in hypothyroidism.
Duranton F; Lacoste A; Faurous P; Deshayes E; Ribstein J; Avignon A; Mourad G; Argilés À
Clin Kidney J; 2013 Oct; 6(5):478-83. PubMed ID: 26064512
[TBL] [Abstract][Full Text] [Related]
7. Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.
Wang Y; Smith TJ
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1735-48. PubMed ID: 24651704
[TBL] [Abstract][Full Text] [Related]
8. Expression of Thyroid Stimulating Hormone Receptor mRNA in Mouse C2C12 Skeletal Muscle Cells.
Ohn JH; Han SK; Park DJ; Park KS; Park YJ
Endocrinol Metab (Seoul); 2013 Jun; 28(2):119-24. PubMed ID: 24396665
[TBL] [Abstract][Full Text] [Related]
9. Functional thyrotropin receptor expression in the ventricle and the effects on ventricular BNP secretion.
Huang W; Xu J; Jing F; Chen WB; Gao L; Yuan HT; Zhao JJ
Endocrine; 2014 Jun; 46(2):328-39. PubMed ID: 24065308
[TBL] [Abstract][Full Text] [Related]
10. Determinants of extraocular muscle volume in patients with graves' disease.
El-Kaissi S; Wall JR
J Thyroid Res; 2012; 2012():368536. PubMed ID: 22496987
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.
Smith TJ; Padovani-Claudio DA; Lu Y; Raychaudhuri N; Fernando R; Atkins S; Gillespie EF; Gianoukakis AG; Miller BS; Gauger PG; Doherty GM; Douglas RS
J Clin Endocrinol Metab; 2011 Dec; 96(12):3827-37. PubMed ID: 21956421
[TBL] [Abstract][Full Text] [Related]
12. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.
Haas AK; Kleinau G; Hoyer I; Neumann S; Furkert J; Rutz C; Schülein R; Gershengorn MC; Krause G
Cell Mol Life Sci; 2011 Jan; 68(1):159-67. PubMed ID: 20652618
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular involvement in patients with different causes of hyperthyroidism.
Biondi B; Kahaly GJ
Nat Rev Endocrinol; 2010 Aug; 6(8):431-43. PubMed ID: 20585347
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?
Lahooti H; Parmar KR; Wall JR
Clin Ophthalmol; 2010 May; 4():417-25. PubMed ID: 20505833
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.
Bunevicius R; Prange AJ
CNS Drugs; 2006; 20(11):897-909. PubMed ID: 17044727
[TBL] [Abstract][Full Text] [Related]
16. Thyroid associated orbitopathy following periocular surgery.
Kim SJ; Kim BJ; Lee HB; Tsirbas A; Kazim M
Korean J Ophthalmol; 2006 Jun; 20(2):82-6. PubMed ID: 16892642
[TBL] [Abstract][Full Text] [Related]
17. Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.
Gopinath B; Musselman R; Beard N; El-Kaissi S; Tani J; Adams CL; Wall JR
Clin Exp Immunol; 2006 Jul; 145(1):56-62. PubMed ID: 16792674
[TBL] [Abstract][Full Text] [Related]
18. Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.
Boschi A; Daumerie Ch; Spiritus M; Beguin C; Senou M; Yuksel D; Duplicy M; Costagliola S; Ludgate M; Many MC
Br J Ophthalmol; 2005 Jun; 89(6):724-9. PubMed ID: 15923509
[TBL] [Abstract][Full Text] [Related]
19. Eye muscle antibodies in Graves' ophthalmopathy: pathogenic or secondary epiphenomenon?
Mizokami T; Salvi M; Wall JR
J Endocrinol Invest; 2004 Mar; 27(3):221-9. PubMed ID: 15164997
[TBL] [Abstract][Full Text] [Related]
20. Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.
Liu SJ; Cai ZW; Liu YJ; Dong MY; Sun LQ; Hu GF; Wei YY; Lao WD
World J Gastroenterol; 2004 May; 10(9):1246-9. PubMed ID: 15112336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
